-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
180 Life Sciences Corp. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2017 to Q3 2023.
- 180 Life Sciences Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was -$2.35M.
- 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2023 was -$2.35M, a 149% decline from 2022.
- 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2022 was -$943K, a 3963% decline from 2021.
- 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2021 was -$23.2K, a 13.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)